Jacob Deweese, OD
Optometrist · Marietta, GANPI 1699437129
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.5%), food and beverage and education — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 62.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $2,668, more than ten times the $97 reported in 2021. Among optometrist clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $114.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$3K
- Johnson & Johnson Vision Care, Inc.$1K
- Bausch & Lomb Americas Inc.$263
- Tarsus Pharmaceuticals, Inc.$187
- Glaukos Corporation$142
- Alcon$124
- plus $36 from 1 others
What the payments were for
- Travel & lodging$2,82558%
- Food & beverage$2,08042%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 20 | $3,092 |
| Johnson & Johnson Vision Care, Inc. | 9 | $1,069 |
| Bausch & Lomb Americas Inc. | 3 | $263 |
| Tarsus Pharmaceuticals, Inc. | 4 | $187 |
| Glaukos Corporation | 1 | $142 |
| Alcon | 5 | $124 |
| Rxsight Inc | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVI Contact Lens$2,037
- Acuvue$937
- INFUSE$241
- iStent inject W$142
- XDEMVY$118
- MyDay Contact Lens$116
- Clariti Contact Lens$105
- MiSight Contact Lens$104
How this compares
$4,912 in reported general payments places this provider in the 90th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 18 | $648 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $145 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Marietta
- Aaron RahnMarietta$29K
- Jinen ShahMarietta$10K
- Sander DorfzaunMarietta$10K
- Ivo HorakMarietta$8K
- Kiran BandaliMarietta$8K
- Joshua JohnstonAtlanta$993K
- John WomackCanton$931K
- Naheed AhmadRoswell$296K
- Scott MoscowRoswell$278K
- Stephen SummerowPerry$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.